Mei Pharma Stock Analysis

MEI Stock Analysis Notes

About 48.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.37. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. MEI Pharma last dividend was issued on the 16th of November 2023. The entity had 1:20 split on the 17th of April 2023. MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California. Mei Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 102 people. To find out more about MEI Pharma contact Daniel Gold at 858 369 7100 or learn more at https://www.meipharma.com.

MEI Pharma Investment Alerts

MEI Pharma Upcoming and Recent Events

MEI Largest EPS Surprises

View All Earnings Estimates

MEI Stock Institutional Investors

Note, although MEI Pharma's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

MEI Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 22.2 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MEI Pharma's market, we take the total number of its shares issued and multiply it by MEI Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

MEI Profitablity

The company has Profit Margin (PM) of 0.27 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.21 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.21.

Management Efficiency

MEI Pharma has return on total asset (ROA) of 0.083 % which means that it generated a profit of $0.083 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.368 %, meaning that it created $0.368 on every $100 dollars invested by stockholders. MEI Pharma's management efficiency ratios could be used to measure how well MEI Pharma manages its routine affairs as well as how well it operates its assets and liabilities. As of 04/25/2024, Return On Tangible Assets is likely to drop to -0.25. In addition to that, Return On Capital Employed is likely to drop to -0.35. At this time, MEI Pharma's Total Current Liabilities is relatively stable compared to the past year. As of 04/25/2024, Liabilities And Stockholders Equity is likely to grow to about 145.9 M, while Non Current Liabilities Total is likely to drop slightly above 46 M.

Technical Drivers

As of the 25th of April, MEI Pharma secures the mean deviation of 2.61, and Risk Adjusted Performance of (0.08). In connection with fundamental indicators, the technical analysis model lets you check helpful technical drivers of MEI Pharma, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to collect and analyze data for thirteen technical drivers for MEI Pharma, which can be compared to its peers in the industry. Please verify MEI Pharma standard deviation and value at risk to decide if MEI Pharma is priced fairly, providing market reflects its recent price of 3.26 per share. Given that MEI Pharma has information ratio of (0.17), we recommend you to check MEI Pharma's last-minute market performance to make sure the company can sustain itself in the future.

MEI Pharma Price Movement Analysis

MEI Pharma Insider Trading Activities

MEI Pharma Predictive Daily Indicators

MEI Pharma Corporate Filings

MEI Pharma Forecast Models

MEI Pharma's time-series forecasting models are one of many MEI Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MEI Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how MEI Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MEI shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as MEI Pharma. By using and applying MEI Stock analysis, traders can create a robust methodology for identifying MEI entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. MEI analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. MEI analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

MEI Pharma stock analysis indicators help investors evaluate how MEI Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading MEI Pharma shares will generate the highest return on investment. By understating and applying MEI Pharma stock analysis, traders can identify MEI Pharma position entry and exit signals to maximize returns.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEI Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in MEI Stock, please use our How to Invest in MEI Pharma guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

When running MEI Pharma's price analysis, check to measure MEI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEI Pharma is operating at the current time. Most of MEI Pharma's value examination focuses on studying past and present price action to predict the probability of MEI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEI Pharma's price. Additionally, you may evaluate how the addition of MEI Pharma to your portfolios can decrease your overall portfolio volatility.

Is MEI Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEI Pharma. If investors know MEI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEI Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of MEI Pharma is measured differently than its book value, which is the value of MEI that is recorded on the company's balance sheet. Investors also form their own opinion of MEI Pharma's value that differs from its market value or its book value, called intrinsic value, which is MEI Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEI Pharma's market value can be influenced by many factors that don't directly affect MEI Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between MEI Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEI Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEI Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.